183 related articles for article (PubMed ID: 27018785)
21. Recent developments in the pathology of germ cell tumors.
Ulbright TM; Roth LM
Semin Diagn Pathol; 1987 Nov; 4(4):304-19. PubMed ID: 2832917
[TBL] [Abstract][Full Text] [Related]
22. Differential methylation of the OCT3/4 upstream region in primary human testicular germ cell tumors.
De Jong J; Weeda S; Gillis AJ; Oosterhuis JW; Looijenga LH
Oncol Rep; 2007 Jul; 18(1):127-32. PubMed ID: 17549357
[TBL] [Abstract][Full Text] [Related]
23. Survival of nonseminomatous germ cell tumors in pediatric patients and young adults - A stage group stratified analysis.
Srivastava A; Patel HV; Koehne E; Gupta GN; Drachtman R; Pierorazio PM; Bagrodia A; Elsamra SE; Kim IY; Ghodoussipour S; Singer EA; Jang TL; Patel HD; Barone JG
Urol Oncol; 2022 Apr; 40(4):169.e1-169.e12. PubMed ID: 35144865
[TBL] [Abstract][Full Text] [Related]
24. Secondary malignancies among nonseminomatous germ cell tumor cancer survivors.
Chamie K; Kurzrock EA; Evans CP; Litwin MS; Koppie TM; Wootton-Gorges SL; Boone JM; Lara PN; Devere White RW
Cancer; 2011 Sep; 117(18):4219-30. PubMed ID: 21412759
[TBL] [Abstract][Full Text] [Related]
25. Resection of residual masses after chemotherapy for advanced non-seminomatous germ cell tumours, a monocentric analysis of pre-operative prognosticators.
Deville JL; Gravis G; Salem N; Savoie PH; Esterni B; Walz J; Thomas P; Goncalves A; Viens P; Bladou F
Eur J Cancer Care (Engl); 2010 Nov; 19(6):827-32. PubMed ID: 19708949
[TBL] [Abstract][Full Text] [Related]
26. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
[TBL] [Abstract][Full Text] [Related]
27. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours.
Rothe M; Albers P; Wernert N
J Pathol; 1999 Aug; 188(4):389-94. PubMed ID: 10440749
[TBL] [Abstract][Full Text] [Related]
29. Cluster analysis of p53 and Ki67 expression, apoptosis, alpha-fetoprotein, and human chorionic gonadotrophin indicates a favorable prognostic subgroup within the embryonal carcinoma germ cell tumor.
Mazumdar M; Bacik J; Tickoo SK; Dobrzynski D; Donadio A; Bajorin D; Motzer R; Reuter V; Bosl GJ
J Clin Oncol; 2003 Jul; 21(14):2679-88. PubMed ID: 12860944
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of p63 in testicular germ cell neoplasia.
Emanuel PO; Unger PD; Burstein DE
Ann Diagn Pathol; 2006 Oct; 10(5):269-73. PubMed ID: 16979518
[TBL] [Abstract][Full Text] [Related]
31. Glypican 3: a novel marker in testicular germ cell tumors.
Zynger DL; Dimov ND; Luan C; Teh BT; Yang XJ
Am J Surg Pathol; 2006 Dec; 30(12):1570-5. PubMed ID: 17122513
[TBL] [Abstract][Full Text] [Related]
32. TCL1 protein expression in testicular germ cell tumors.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2010 May; 133(5):762-6. PubMed ID: 20395523
[TBL] [Abstract][Full Text] [Related]
33. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.
Kawakami T; Okamoto K; Sugihara H; Hattori T; Reeve AE; Ogawa O; Okada Y
J Urol; 2003 Apr; 169(4):1546-52. PubMed ID: 12629412
[TBL] [Abstract][Full Text] [Related]
34. Recent developments in testicular germ cell tumor research.
van de Geijn GJ; Hersmus R; Looijenga LH
Birth Defects Res C Embryo Today; 2009 Mar; 87(1):96-113. PubMed ID: 19306344
[TBL] [Abstract][Full Text] [Related]
35. [Histopathology of testicular germ cell tumors].
Morinaga S; Sasano N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2460-7. PubMed ID: 6210048
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in molecular and cell biology of testicular germ-cell tumors.
Chieffi P
Int Rev Cell Mol Biol; 2014; 312():79-100. PubMed ID: 25262239
[TBL] [Abstract][Full Text] [Related]
37. [Flow cytometric analysis of DNA content in adult testicular germ cell tumors].
Kashiwagi A; Nagamori S; Nonomura K; Toyota K; Koyanagi T; Nojima T; Inoue K
Nihon Hinyokika Gakkai Zasshi; 1992 Jul; 83(7):1062-70. PubMed ID: 1324379
[TBL] [Abstract][Full Text] [Related]
38. Gene expression-based classification of nonseminomatous male germ cell tumors.
Korkola JE; Houldsworth J; Dobrzynski D; Olshen AB; Reuter VE; Bosl GJ; Chaganti RS
Oncogene; 2005 Jul; 24(32):5101-7. PubMed ID: 15870693
[TBL] [Abstract][Full Text] [Related]
39. The management of stage I nonseminomatous testicular germ cell tumors.
Pectasides D; Farmakis D; Pectasides M
Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
[TBL] [Abstract][Full Text] [Related]
40. Mediastinal Germ Cell Tumor and Acute Megakaryoblastic Leukemia With Co-occurring KRAS Mutation and Complex Cytogenetics.
Amra N; Zarate LV; Punia JN; Mahajan P; Stevens AM; Roy A; Curry CV; Cortes-Santiago N; Fisher KE
Pediatr Dev Pathol; 2020; 23(6):461-466. PubMed ID: 32815783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
